COVID-19: WHO Suspends Trials of Hydroxychloroquine


The World Health Organization (WHO) said testing of the malaria drug hydroxychloroquine as a possible treatment for coronavirus has been halted because of safety fears.

Trials in several countries are being temporarily suspended as a precaution.

It comes after a recent medical study suggested the drug could increase the risk of patients dying from COVID-19.

United States President Donald Trump has promoted the anti-malarial drug, despite warnings from public health officials that it could cause heart problems in COVID-19 patients.

Trump also said he was taking the drug himself to ward off the virus, but said in Sunday he was not taking it any more.


Please enter your comment!
Please enter your name here

three + 20 =

This site uses Akismet to reduce spam. Learn how your comment data is processed.